Tuesday, May 30, 2017 4:51:56 PM
If the company fulfills its intended direction with FDA support, then the value is much higher.
If there's some sort of detrimental aspect lurking in the background that investors aren't aware of, then we'd be in for a shock of a drop.
Many many eyes on shorting it down and then picking it up at what many are hoping to be a 'more reasonable' price.
I just keep thinking of the chase. I did it once after I sold my initial block acquired at .04 - am looking forward to hearing something from the company.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM